Insider · CIK 0001339484

Poma Eric E

Reports to the SEC for 3 companies · SAN DIEGO,, CA

sec.gov

Transactions

Companies

Filings

CIK

0001339484

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-17	CLDICalidi Biotherapeutics, Inc. · Stock Options (right to buy)A Award	Chief Executive Officer	AAward	+32K sh	—	—	32,000
2025-09-03	CLDICalidi Biotherapeutics, Inc. · Stock Options (right to buy)A Award	Chief Executive Officer	AAward	+10K sh	—	—	10,000
2025-08-21	CLDICalidi Biotherapeutics, Inc. · Warrant (right to buy)P Purchase	Chief Executive Officer	PPurchase	+25K sh	—	—	25,000
2025-08-21	CLDICalidi Biotherapeutics, Inc.P Purchase	Chief Executive Officer	PPurchase	+25K sh	$2.00	+$50K	25,000
2025-04-22	CLDICalidi Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+726K sh	—	—	726,412
2024-01-23	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+23.3K sh	—	—	23,333
2023-02-15	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+400K sh	—	—	400,000
2022-04-27	Molecular Templates, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See remarks	MExercise/Conversion	−6,831 sh	—	—	0
2022-04-27	Molecular Templates, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See remarks	MExercise/Conversion	−27.3K sh	—	—	0
2022-04-27	Molecular Templates, Inc.M Exercise/Conversion	Director, See remarks	MExercise/Conversion	+27.3K sh	$0.71	+$19.4K	277,615
2022-04-27	Molecular Templates, Inc.M Exercise/Conversion	Director, See remarks	MExercise/Conversion	+6,831 sh	$0.71	+$4,850.01	250,290
2022-02-15	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+300K sh	—	—	300,000
2021-07-06	Molecular Templates, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See remarks	MExercise/Conversion	−3,563 sh	—	—	0
2021-07-06	Molecular Templates, Inc.M Exercise/Conversion	Director, See remarks	MExercise/Conversion	+3,563 sh	$0.71	+$2,529.73	243,459
2021-02-15	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+300K sh	—	—	300,000
2020-02-14	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+313K sh	—	—	312,500
2019-02-15	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+250K sh	—	—	250,000
2018-11-26	Molecular Templates, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See remarks	MExercise/Conversion	−87K sh	—	—	3,563
2018-11-26	Molecular Templates, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See remarks	MExercise/Conversion	−153K sh	—	—	0
2018-11-26	Molecular Templates, Inc.M Exercise/Conversion	Director, See remarks	MExercise/Conversion	+87K sh	$0.71	+$61.7K	239,896
2018-11-26	Molecular Templates, Inc.M Exercise/Conversion	Director, See remarks	MExercise/Conversion	+153K sh	$0.42	+$64.2K	152,945
2018-05-31	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+200K sh	—	—	200,000
2018-05-31	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+585K sh	—	—	585,126
2017-10-09	Molecular Templates, Inc.Stock Option (right to buy)A Award	Director, See remarks	AAward	+275K sh	—	—	275,000
2007-07-10	CytRx Oncology CorpStock Option (Right to BuyA Award	VP - Business Development	AAward	+37.5K sh	—	—	37,500
2007-07-10	CytRx Oncology CorpStock Option (Right to Buy)A Award	VP - Business Development	AAward	+37.5K sh	—	—	37,500

Recent filings

Accepted (ET)
Aug 194
Poma Eric E0001493152-26-039287
SEC(opens sec.gov)
Sep 54
Poma Eric E0001641172-25-026782
SEC(opens sec.gov)
Aug 254
Poma Eric E0001641172-25-025447
SEC(opens sec.gov)
Apr 254
Poma Eric E0001641172-25-006070
SEC(opens sec.gov)
Jan 254
Poma Eric E0000950170-24-007535
SEC(opens sec.gov)
Feb 174
Poma Eric E0000899243-23-005365
SEC(opens sec.gov)
Apr 294
Poma Eric E0000899243-22-015976
SEC(opens sec.gov)
Feb 174
Poma Eric E0000899243-22-006729
SEC(opens sec.gov)
Jul 74
Poma Eric E0000899243-21-027737
SEC(opens sec.gov)
Feb 174
Poma Eric E0000899243-21-006902
SEC(opens sec.gov)
Feb 184
Poma Eric E0000899243-20-004988
SEC(opens sec.gov)
Feb 204
Poma Eric E0000899243-19-004259
SEC(opens sec.gov)
Nov 294
Poma Eric E0000899243-18-029818
SEC(opens sec.gov)

Companies

Address

C/O CALIDI BIOTHERAPEUTICS, INC. 4475 EXECUTIVE DRIVE, SUITE 200

SAN DIEGO,, CA, 92121